SWITZERLAND – GlaxoSmithKline’s ViiV Healthcare has committed to grant voluntary license on the patents for its injectable HIV prevention drug to make it more widely available in poorer nations, where…
Read MoreViiV pledges to license its patents on long-acting cabotegravir for HIV pre-exposure prophylaxis
